IL32 was reported to accelerates the proliferation of cutaneous T-cell lymphoma cell lines through mitogen-activated protein kinase (MAPK) and NF-κB signaling pathways [23]. Here, NFKB1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.